Claude Sportès - Concepedia

Author

Claude Sportès

National Cancer Institute

Also Known As

C Sportes, C. Sportes, Claude Sportes, Claude Sportès, Claude Sportès, Claude Sportés

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute Center for Cancer Research National Institutes of Health National Institutes of Health Clinical Center Hackensack University Medical Center

About

Claude Sportès is an author at National Cancer Institute specializing in medicine, cell transplantation, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	679
2	Cell Biology	4	4	498
3	Health Sciences	3	3	105
4	Cellular Therapies	2	2	92
5	Blood Transplantation	1	1	13

Claude Sportès

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation James N. Kochenderfer, Mark E. Dudley, Robert O. Carpenter, Blood	2013	586
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets Claude Sportès, Frances T. Hakim, Sarfraz Memon, The Journal of Experimental Medicine	2008	462
IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells Steven A. Rosenberg, Claude Sportès, Mojgan Ahmadzadeh, Journal of Immunotherapy Il-7 AdministrationCd4+ CellsT-regulatory CellImmune RegulationImmunology	2006	440
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States Jeffrey I. Cohen, Elaine S. Jaffe, Janet K. Dale, Blood	2011	299
Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy Claude Sportès, Rebecca Babb, Michael Krumlauf, Clinical Cancer Research	2010	214
National Institutes of Health Chronic Graft-versus-Host Disease Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Severity and Prognosis Kristin Baird, Seth M. Steinberg, Lana Grković, Biology of Blood and Marrow Transplantation	2013	91
Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation Michael Bishop, Robert M. Dean, Seth M. Steinberg, Annals of Oncology Lymphoid NeoplasiaCell TherapyTransplantationMarrow TransplantationStem Cell Transplantation	2008	78
Phase I Clinical Trial of Costimulated, IL-4 Polarized Donor CD4+ T Cells as Augmentation of Allogeneic Hematopoietic Cell Transplantation Daniel H. Fowler, Jeanne Odom, Seth M. Steinberg, Biology of Blood and Marrow Transplantation	2006	56
Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial Amber B. Clemmons, Julianne Orr, Benjamin Andrick, Biology of Blood and Marrow Transplantation Emetogenic ChemotherapyOncologyMinimal NauseaChemotherapy-induced NauseaMedicine	2018	54
Oral Mucositis-Related Oropharyngeal Pain and Correlative Tumor Necrosis Factor-α Expression in Adult Oncology Patients Undergoing Hematopoietic Stem Cell Transplantation Jane M. FalI-Dickson, Edward S. Ramsay, Kathleen M. Castro, Clinical Therapeutics InflammationOral CavityPathologyOral BiologyMedicine	2007	36

Page 1